However, combination with high-dose ACEI could increase blood pressure
Conclusion This updated meta-analysis of randomised clinical trials demonstrated that the use of semaglutide in patients with or without T2DM was not associated with an increased risk of acute pancreatitis compared to placebo
Wegovy (semaglutide 2.4 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or obstructive sleep apnoea
Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
Ding Y, Zhou YY, Chen H, Geng DD, Wu DY, Hong J, et al